Blm-s, a BH3-Only Protein Enriched in Postmitotic Immature Neurons, Is Transcriptionally Upregulated by p53 during DNA Damage  by Liu, Wei-Wen et al.
ArticleBlm-s, a BH3-Only Protein Enriched in Postmitotic
Immature Neurons, Is Transcriptionally Upregulated by
p53 during DNA DamageGraphical AbstractHighlightsBLM-s is a BH3-only apoptosis sensitizer/derepressor of the
BCL-2 family
Blm-s plays a role in apoptosis of postmitotic immature cortical
neurons
Blm-s is transcriptionally upregulated by the ATM/p53- and
JNK/AP1-signaling pathways
Blm-s is a direct target of p53 and AP1 in response to DNA dou-
ble-strand breaksLiu et al., 2014, Cell Reports 9, 166–179
October 9, 2014 ª2014 The Authors
http://dx.doi.org/10.1016/j.celrep.2014.08.050Authors
Wei-Wen Liu, Shih-Yu Chen, ..., Hwai--
Jong Cheng, Pei-Hsin Huang
Correspondence
hjcheng@ucdavis.edu (H.-J.C.),
phhuang@ntu.edu.tw (P.-H.H.)
In Brief
Liu et al. describe a Bcl-2 family gene,
Blm-s, that is specifically expressed in
postmitotic immature neurons during em-
bryonic development. When the devel-
oping brain is challenged with g-irradia-
tion that produces DNA double-strand
breaks (DBSs), Blm-s is upregulated in
the neurons that undergo cell death.
Depletion of Blm-s prevents immature
neurons from irradiation-induced death.
The authors also show that Blm-s is a
direct target of p53 and AP1 via the
signaling pathways activated by DSBs.
Accession NumbersDQ869383
Cell Reports
ArticleBlm-s, a BH3-Only Protein Enriched in Postmitotic
Immature Neurons, Is Transcriptionally Upregulated
by p53 during DNA Damage
Wei-Wen Liu,1 Shih-Yu Chen,4 Chia-Hsien Cheng,2 Hwai-Jong Cheng,3,4,* and Pei-Hsin Huang1,5,*
1Graduate Institute of Pathology
2Graduate Institute of Oncology
3Graduate Institute of Brain and Mind Sciences
College of Medicine, National Taiwan University, Taipei 100, Taiwan
4Department of Neurobiology, Physiology and Behavior, Department of Pathology and Laboratory Medicine, and Center for Neuroscience,
University of California, Davis, Davis, CA 95618, USA
5Department of Pathology, National Taiwan University Hospital, Taipei 100, Taiwan
*Correspondence: hjcheng@ucdavis.edu (H.-J.C.), phhuang@ntu.edu.tw (P.-H.H.)
http://dx.doi.org/10.1016/j.celrep.2014.08.050
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARY
Programmed cell death is a pivotal process that
regulates neuronal number during development.
Key regulators of this process are members of the
BCL-2 family. Using mRNA differential display, we
identified aBcl-2 family gene,Blm-s (Bcl-2-likemole-
cule, short form), enriched in postmitotic neurons
of the developing cerebral cortex. BLM-s functions
as a BH3-only apoptosis sensitizer/derepressor
and causes BAX-dependent mitochondria-mediated
apoptosis by selectively binding to prosurvival BCL-
2 or MCL-1. When challenged with g-irradiation that
produces DNA double-strand breaks (DSBs), Blm-s
is transcriptionally upregulated in postmitotic imma-
ture neurons with concurrently increased apoptosis.
RNAi-mediated depletion of Blm-s protects imma-
ture neurons from irradiation-induced apoptosis.
Furthermore, Blm-s is a direct target gene of p53
and AP1 via the ataxia telangiectasia mutated
(ATM)- and c-Jun N-terminal kinase (JNK)-signaling
pathways activated by DSBs. Thus, BLM-s is likely
an apoptosis sensor activated by DSBs accumu-
lating in postmitotic immature neurons.
INTRODUCTION
A crucial component of normal brain morphogenesis is pro-
grammed cell death, or apoptosis. It is estimated that more
than 50% of the generated neurons during brain development
undergo apoptosis, which occurs in both proliferative neural
precursor cells and postmitotic immature neurons (Oppenheim,
1991; Kuan et al., 2000; Nijhawan et al., 2000; Buss et al., 2006;
Underwood, 2013). Neuronal apoptosis, like apoptosis in other
cell types, proceeds either through an extrinsic pathway where
cells are instructed to commit cell death by ligand-receptor inter-166 Cell Reports 9, 166–179, October 9, 2014 ª2014 The Authorsaction or through an intrinsic pathway where apoptosis is initi-
ated via intracellular stresses. Both pathways could be regulated
by the core mitochondrial apoptosis molecular machinery that
comprises the BCL-2 family members, caspases, and apopto-
somes (Riedl and Salvesen, 2007; Brenner and Mak, 2009).
BCL-2 family proteins, sharing common BCL-2 homology (BH)
domains, are functionally divided into three groups (Chipuk et al.,
2010; Llambi et al., 2011; Martinou and Youle, 2011). The proap-
optotic multidomain group, including BAX and BAK, directly dis-
rupts mitochondrial integrity and causes apoptosis. The prosur-
vival group, including BCL-2, A1, MCL-1, and BCL-xL, inhibits
the activity of proapoptotic members. The BH3-only proapopto-
tic group, including BIM, BAD, BID, NOXA, and PUMA, shares
the BH3 domain and activates proapoptotic BAX/BAK to pro-
mote apoptosis either by directly interacting with BAX (referred
to as ‘‘apoptosis-direct activators’’) or by interacting with pro-
survival BCL-2 members to release BAX (‘‘apoptosis sensi-
tizers/derepressors’’). This BH3-only group functions as major
sensors for apoptosis stimuli and acts as initiators of apoptosis
in a tissue-specific and stimulus-specific manner (Shamas-
Din et al., 2011). Currently, over 40 members of the BCL-2
family are discovered in mammals, and they together execute
a life-or-death decision via a rheostat model determined by the
integrated action of all involved proapoptotic and prosurvival
BCL-2 molecules (Shacka and Roth, 2006; Youle and Strasser,
2008).
What causes massive apoptosis in the developing nervous
system? The developing brain is susceptible to deleterious
DNA damage including DNA double-strand breaks (DSBs)
(Cheng et al., 2007; Lee and McKinnon, 2007; Frappart and
McKinnon, 2008). DNA damage could result from naturally
occurring metabolic products, DNA replication, and DNA tran-
scription. Accumulated DSBs during neural development can
be repaired either by a homologous recombination (HR) pathway
preferentially utilized by proliferative neural precursor cells or by
a nonhomologous end-joining (NHEJ) pathway predominantly
employed by postmitotic immature neurons (Orii et al., 2006;
Lee and McKinnon, 2007). However, the irreparable DSBs
eventually initiate developmental neuronal apoptosis. This
theory is supported by at least two pieces of evidence. First,
Xrcc2/ embryonic brains that lack the HR pathway display
widespread apoptosis in their proliferative ventricular zone (Orii
et al., 2006). Second, Ku70, Xrcc4, and Lig4 mutants that are
deficient in the NHEJ pathway exhibit massive apoptosis in
their postmitotic immature neurons (Barnes et al., 1998; Gao
et al., 1998; Narasimhaiah et al., 2005; Frappart and McKinnon,
2008; Gatz et al., 2011). Once DNA damage has begun, neuronal
apoptosis can proceed either through phosphorylated ataxia
telangiectasia mutated (ATM)/p53 signaling or through c-Jun
N-terminal kinase (JNK)-mediated AP1 transcriptional activity
(Zhou and Elledge, 2000; Roos and Kaina, 2006; Lee andMcKin-
non, 2007). Accordingly, misregulation of molecules in these
signaling pathways can produce neurons that are susceptible
to apoptosis.
Consistent with the differential utilization of DNA damage
repair pathways in the proliferative and postmitotic neurons dur-
ing cortical neurogenesis, the regulations of apoptosis in the
proliferative and postmitotic cortical zones are also distinct so
that the BCL-2 family members are differentially expressed in
these two zones throughout embryonic brain development. For
example, proapoptotic BAX is required for postmitotic neuronal
apoptosis but is dispensable for apoptosis in the proliferative
zone (Shindler et al., 1997; D’Sa-Eipper et al., 2001). The
proapoptotic BH3-only PUMA and NOXA are predominantly ex-
pressed in the proliferative neuronal precursors and are respon-
sible for their apoptosis (Akhtar et al., 2006). It is interesting to
note that, although the BH3-only proteins are important initiators
for neuronal apoptosis, none of the more than ten members that
have been examined to date by gene-disruption studies are re-
ported to be critical for postmitotic neuronal apoptosis (Leonard
et al., 2001; Ranger et al., 2001; Akhtar et al., 2008; Ghosh et al.,
2011).
Here, we report the identification and characterization of a
Bcl-2 family member, Blm-s, which is expressed specifically in
the postmitotic intermediate zone and cortical plate of mouse
embryonic brains during a narrow developmental time window
coincident with cortical histogenesis. We show that BLM-s func-
tions as a BH3-only apoptosis sensitizer/derepressor to promote
neuronal apoptosis and is transcriptionally upregulated in a p53-
dependent manner in response to DSBs.
RESULTS
Blm-s Is a Bcl-2 Family Member Specifically Expressed
in the Embryonic Nervous System
Using mRNA differential display strategies (Figure S1A; Liang
and Pardee, 1992), we identified 115 distinct DNA sequences
that were mostly upregulated in the mouse embryonic CNS.
Among them is a 485 bp DNA fragment homologous to human
CCDC132 gene (Figure 1A; Matsumoto et al., 2010). RNA
in situ hybridization confirmed that this gene is expressed specif-
ically in the embryonic nervous system and is highly enriched in
the postmitotic intermediate zone (IZ) and cortical plate (CP)
(Figure 1B). Northern blot analysis of mouse embryonic tissues
detected two mRNA isoforms with the long 4.0 kb transcript ex-
hibiting constant low expression from embryonic day 7 (E7) toE17 and the short 1.1 kb isoform substantially upregulated at
E15 and E17 (Figure 1C). The longest open reading frame deter-
mined by 50-RACE and cDNA library screening contains 2,895
nucleotides, which presumably encodes the 4.0 kb transcript.
Primer extension concluded that the promoter for the 1.1 kb iso-
form is located within the 24th intron that harbors the TATA-box-
protein-binding site6657 base pair upstream of the defined
transcription start site (Figures S1B and S1C).
Motif search by informed visual inspection combined with
PSIPRED database predicted the presence of BH2 and BH3mo-
tifs together with eight a helices (Figure 1D), suggesting that this
gene could be a new member of the Bcl-2 family. Phylogenetic
tree analysis also demonstrated that this gene, similar to the
defined BCL-2 family homologs, exists throughout the evolution
of metazoans, but not in single-cell organisms (Figures S2A–
S2C; Aouacheria et al., 2013). We thus designate this gene as
Bcl-2-like molecule (Blm) (also named as Blm-l) for its long
isoform 4.0 kb transcript and the 1.1 kb isoform as Bcl-2-like
molecule, short form (Blm-s) (GenBank accession number
DQ869383). Here, we focus on characterizing BLM-s because
(1) Blm-s is expressed primarily in developing mouse embryos
and minimally in adult tissues (Figures 1C and S1D) and
(2) Blm-s expression is specific in the narrow but critical devel-
opmental time window of E14–E17, when the developing ner-
vous system is undergoing cortical morphogenesis (Figures 4A
and 4B).
Overexpression of BLM-s Promotes Apoptosis
To test whether BLM-s acts like other BCL-2 family proteins in
the regulation of cell survival, we first transiently expressed
Blm-s in COS cells that have undetectable endogenous BLM-s
(Figures 6A and S5B). Many Blm-s-expressing cells were
apoptotic, as evidenced by shrunken cell morphology, chro-
matin condensation, and DNA hypoploidy (Figures 2A–2C and
S3A). The apoptosis is specific to Blm-s because it was blocked
by coexpressing Blm-s RNAi (siBlm-s) constructs (Figures 2A–
2C) and was not caused by ER-stress-induced unfolded protein
response or proteotoxicity resulting from protein overexpression
(Figures S3C–S3E). We next overexpressed Blm-s in dissociated
cortical neurons from E15.5 mouse embryos. Neurons trans-
fected with Blm-s underwent apoptosis, displaying extensive
neurite fragmentation and shrunken cell somas with nuclear
condensation (Figure 2D). In line with BLM-s’s proapoptotic
role, our attempts to generate cell lines that stably express
BLM-s in NG108, HeLa, Neuro2a, and COS cells all failed. Mea-
surement of long-term cell viability using colony formation assay
also showed that Blm-s-transfected cells yielded only one-tenth
as many colonies as mock control (Figure S3B). These data
together indicate that overexpressing Blm-s induces apoptosis
in both neuronal and nonneuronal cells.
To directly assess the function of BLM-s in the nervous system
in vivo, we overexpressed Blm-s in the developing brain by
in utero intraventricular electroporation (IUEP) and assayed its
effect on apoptosis by TUNEL stain. In the mouse embryonic
cortices, the apoptosis detected by TUNEL is reported to be
less than 1% (Gilmore et al., 2000; Kuan et al., 2000), which is
consistent with what we saw in the uninjected or the mock-in-
jected brains (Figures 2E–2G). By contrast, around 25% of cellsCell Reports 9, 166–179, October 9, 2014 ª2014 The Authors 167
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Figure 1. Identification of Blm-s in Mouse Embryonic Nervous System
(A) mRNA differential display of E15.5 mouse embryonic brain and nonneuronal tissue. Arrow: a 485 bp fragment enriched in the embryonic brain.
(B) RNA in situ hybridization of E15.5 mouse embryonic brain (left panel) and spinal cord (right bottom panels) probed by the 485 bp fragment. The boxed area is
enlarged and shown in the upper middle panel with a control (sense) shown in the upper right panel. CP, cortical plate; DRG, dorsal root ganglion; IZ, intermediate
zone; SVZ, subventricular zone; VZ, ventricular zone; scale bar, 100 mm.
(C) Northern blot of mouse embryonic tissues probed with the 485 bp fragment.
(D) Schematic diagram of the predicted BLM-s protein domain structure (top). The numbers indicate the amino acid sequence positions. DRPK, an ERmembrane
retention signal; BH2 and BH3: BCL-2 homology domain 2 and 3. The bottom panels show the sequence alignments of the BH domains of BLM-s with other
mouse BCL-2 family members. Highly conserved residues are indicated in red.expressing Blm-s appeared pyknotic and were TUNEL positive
(Figures 2E and 2G), which were specifically abolished by coex-
pressing siBlm-s (Figures 2H and 2I). The apoptotic effects were
unlikely due to nonspecific protein overexpression because the
expression levels of the various injected plasmids were similar
(Figure S3F). Interestingly, the TUNEL-positive cells in the normal
developing brain were usually scattered, but the Blm-s-overex-
pressing apoptotic cells appeared in clusters and spread across
all layers, indicating that BLM-s is capable of inducing apoptosis
in the regions where Blm-s is not normally expressed in vivo. At-
tempts to RNAi knock down Blm-s in mouse embryonic brain168 Cell Reports 9, 166–179, October 9, 2014 ª2014 The Authorswere however uninformative because of the low apoptotic rate
(<1%) in the normal embryonic brain as assayed by TUNEL.
Nevertheless, our data collectively indicate that both in vitro
and in vivo expression of BLM-s in the developing immature neu-
rons promote apoptosis.
BLM-s Is a BH3-Only Apoptosis Sensitizer/Derepressor
Apoptosis proceeds through cascades of activated caspases
either via an extrinsic death-receptor-mediated pathway or an
intrinsic mitochondrial pathway (Ola et al., 2011). Inhibiting cas-
pase-8 (Z-IETD-fmk) or caspase-12 (Z-ATAD-fmk) did not block
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BLM-s-mediated apoptotic activity in transfected COS cells, but
adding Z-DEVD-fmk (a caspase-3 inhibitor) or Z-VAD-fmk (a
broad-spectrum caspase inhibitor) did confer partial or complete
protection against BLM-s-mediated apoptosis (Figure S4A),
indicating an intrinsic mitochondrial pathway is involved. In sup-
port, lysates derived from BLM-s-expressing COS cells showed
poly ADP-ribose polymerase (PARP) cleavage by activated cas-
pase-3 (Figure S4B), and Blm-s-transfected cortical neurons or
COS cells displayed cytochrome c release from mitochondria
into the cytosol that activates caspase-3 (Figures 3A, 3B, S4C,
and S4D).
The subcellular localization studies showed that BLM-s is co-
localized with the mitochondria marker mitotracker and the ER
marker calnexin in transfected COS cells (Figure S4E). In accor-
dance, BLM-s is enriched in the mitochondria-enriched heavy
membrane (HM) (labeled by Hsp60) and in the ER-enriched light
membrane (LM) (labeled by calnexin) by differential centrifuga-
tion (Figure 3C). Immunogold electron microscopy also demon-
strated that BLM-s resides in the cristae and outermembranes of
mitochondria as well as in the ER membranes (Figure 3D). Thus,
BLM-s localizes to the ER and mitochondria and promotes
apoptosis via an intrinsic mitochondrial pathway that involves
cytochrome c release and subsequent caspase-3 activation.
The BH domains are required to form protein complex among
the BCL-2 familymembers and are critical to their death-promot-
ing/protecting functions (Chipuk et al., 2010). To examine the
role of BH domains in BLM-s-mediated apoptosis, we generated
BLM-s mutants harboring altered critical residues in the BH do-
mains (Figure 3E). Each of the BLM-s mutants was properly ex-
pressed and localized to the ER and mitochondria (Figure S4F).
However, cells transfected with these mutants did not show
apoptosis (Figures 3F and S4G). Likewise, IUEP analysis re-
vealed BLM-s-BH mutants did not induce apoptosis in vivo
(Figures 3G and 3H). These results indicate that both the BH3
and BH2 domains of BLM-s are necessary for BLM-s-mediated
apoptosis.
Both coimmunoprecipitation and yeast two-hybrid analysis
showed that BLM-s selectively interacts with prosurvival BCL-
2 and MCL-1, but not with proapoptotic multidomain BAX and
BAK (Figures 3I and S4L). Such interactions were further
confirmed by colocalization in transfected cells (Figure S4K)Figure 2. Overexpressing BLM-s Induces Apoptosis In Vitro and In Viv
(A) COS cells transfected with Blm-s-GFP alone (top) or with mCherry-Blm-s an
siBlm-s cause apoptosis (empty arrowheads). H33258, nuclear stain; Phase, pha
(B) The knockdown efficiency of three siBlm-s constructs in COS cell was assess
182, nt. 474–492, and nt. 292–310 (DQ869383), respectively. The remaining BLM
control.
(C) The apoptotic rates (%) induced by transfecting COS cells with Blm-s or othe
determined by two-tailed unpaired Student’s t test (***p < 0.001; **p < 0.01; *p <
graphs).
(D) The apoptotic rates (%) of dissociated E15.5 cortical neurons transfected withB
10 mm.
(E–I) Effects of overexpressing BLM-s in embryonic cortices in vivo. Shown are E1
ormCherry-Blm-s plus siBlm-s-GFP (H) by IUEP at E14.5. Quantifications of apop
(I). The number of cells counted for each condition (N=) is indicated in the bar
examined: 10 for BLM-s-GFP, 13 for mCherry-BLM-s, 10 for Mock-GFP, and 8 fo
was estimated by the ratio of TUNEL+ cells to H33258+ cells (uninjected; n = 3
transfected cells without TUNEL signals. The scale bars represent 50 mm (white)
170 Cell Reports 9, 166–179, October 9, 2014 ª2014 The Authorsand by coimmunoprecipitating endogenous BLM-s with BCL-2
and MCL-1 from E15.5 embryonic brain lysate (Figure 3J). The
binding of BCL-2 and MCL-1 to BLM-s is direct, as demon-
strated by in vitro glutathione S-transferase (GST) pull-down
assay (Figure 3K). These interactions require BLM-s’s two
BH domains because none of the BLM-s-BH mutants formed
protein complexes with BCL-2 (Figures S4H–S4J), and the
BCL-20s BH2 and BH3 domains were reciprocally required for
its specific interactionwith BLM-s (Figure S4O). Thus, the BHdo-
mains of BLM-s are necessary, not only for its apoptosis-
inducing function, but also for its interaction with prosurvival
MCL-1 and BCL-2.
The rheostat model proposed to mediate survival-or-death
decisions by BCL-2 family members states that overexpression
of prosurvival BCL-2 leads to inhibition of stimulus-induced
apoptosis whereas overexpression of proapoptotic ones causes
increased sensitivity to apoptotic stimuli (Shacka and Roth,
2006; Youle and Strasser, 2008). We reasoned that overexpress-
ing BCL-2 or MCL-1 in Blm-s-transfected cells would counteract
BLM-s’s proapoptotic effect. As expected, overexpressing BCL-
2 partially rescued BLM-s-mediated apoptosis (Figure S4N) and
prohibited BLM-s-induced cytochrome c release (Figure S4K).
Thus, in the regulation of cell death, BLM-s behaves like the
BH3-only proapoptotic members of the BCL-2 family. However,
unlike those BH3-only apoptosis-direct activator proteins such
as PUMA and tBID that directly interact and activate BAX,
BLM-s does not interact with BAX, which is evident by yeast-
two-hybrid, coimmunoprecipitation, and GST pull-down assays
(Figures 3I, 3J, S4L, and S4M). Nevertheless, BAX is required for
BLM-s-mediated apoptosis because this apoptosis is not
observed in embryonic cortical neurons expressing BLM-s with
concomitant BAX depletion (Figure 3L), in 293T cells containing
small amounts of BAX (Figures S5A and S5B), or in cells with
RNAi-mediated depletion of Bax (Figures S4N, S5C, and S5D).
In accordance, reintroducing BAX into either of these cell groups
restored apoptosis induced by BLM-s (Figure S5D). All together,
our results demonstrate that BLM-s behaves like a BH3-only
apoptosis sensitizer/derepressor that promotes apoptosis by
sensitizing and liberating BAX/BAK or other BH3-only apoptosis
activators from inhibitory interaction with prosurvival MCL-1 or
BCL-2.o
d GFP-siBlm-s (bottom). Note that mCherry-Blm-s-transfected cells without
se contrast image. The scale bar represents 20 mm.
ed by western blot. siBlm-s no. 1, no. 2, and no. 3 target nucleotides (nt.) 164–
-s-GFP after each knockdown is quantified (ratio) using a-tubulin as a loading
r key Bcl-2 family genes. Values are mean ± SD, and statistical significance is
0.05; n = 9 assays; same annotations and statistics are used for the rest of bar
lm-s. n = 109 for BLM-s-GFP and 694 for Mock-GFP. The scale bar represents
7.5 embryonic cortical sections transfected withBlm-s-GFP (E),Mock-GFP (F),
totic cells (TUNEL+) for each transfection are summarized in bar graphs (G) and
(same annotations are used for the rest of bar graphs). The number of mice
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Figure 3. BLM-s Is a BCL-2 Family Member and Selectively Interacts with Prosurvival BCL-2 and MCL-1
(A and B) E15.5 cortical neurons cultured in vitro for 5 days (DIV5) and transfected withBlm-s-GFP orMock-GFP stained by anti-activated caspase-3 antibody (A)
or by anti-cytochrome c antibody (B). The boxed areas in (B) are shown to the right with signal enhancement. The scale bars represent 20 mm.
(C) Subcellular fractionation analysis of COS cells transfected with Blm-s, Bax, or Bcl-2. HSP60 and calnexin are mitochondria and ER markers, respectively. P,
low speed pellet; HM, heavy membrane; LM, light membrane; S, soluble cytosolic fraction; H, homogenate.
(D) Immunogold electron microscopic images of Blm-s-GFP-transfected COS cells.
(legend continued on next page)
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Blm-s Is Transcriptionally Upregulated in Postmitotic
Immature Neurons by DSBs Transduced through the
ATM/p53- and JNK/AP1-Signaling Pathways
Blm-s is abundantly expressed in embryonic brains around
E14.5–E16.5 (Figures 4A and 4B) when apoptosis in embryonic
brain proceeds concurrently with naturally occurring DSBs (Nar-
asimhaiah et al., 2005). Specifically, Blm-s is expressed in the
postmitotic IZ/CP regions labeled by Tuj1 and doublecortin
and is generally absent in Ki67-labeled neuronal precursor cells
in the ventricular/subventricular zones (VZ/SVZ) (Figure 4C).
Because DSBs are implicated in triggering apoptosis of postmi-
totic immature neurons (Cheng et al., 2007), the restricted
expression of proapoptotic Blm-s to the postmitotic neurons of
the developing mouse cortices suggests a functional correlation
of BLM-s to DSBs. Indeed, Blm-s-expressing cells at E15.5
embryonic brain were colabeled with serine-139-phosphory-
lated H2A.X (g-H2A.X), an immediate responder that is g-phos-
phorylated enmasse by activated ATM at the site of DSBs within
1–3 min (Rogakou et al., 1999; Bekker-Jensen et al., 2006; Fig-
ure 4D). To further demonstrate that Blm-s could be transcrip-
tionally upregulated by DSBs in vivo, we challenged mouse
embryos with g-irradiation (g-IR) that caused DSBs. g-IR signif-
icantly increased the amount of Blm-s transcript in the IZ/CP re-
gion and up to 40% of Blm-s-positive cells were TUNEL positive
4 hr after g-IR (Figure 4E). Besides, the number of cells coex-
pressing Blm-s transcripts and g-H2A.X was increased upon
g-IR treatment (Figure 4D). Conversely, depletion of endogenous
BLM-s by IUEP of siBlm-s in E15.5 embryonic cortices rendered
cells resistant to g-IR-induced apoptosis (Figures 4F and 4G).
Similarly, Blm-s transcript in neural-derived NG108 cells was
specifically induced by DSBs-generating agents such as etopo-
side and g-IR, but not by UV irradiation or H2O2 treatment that
causes other types of DNA damage (Figure S6A). Together,
these data indicate the requirement of BLM-s as an apoptosis
executor in postmitotic immature neurons when triggered by
DSBs.
We next explored whether the concurrent transcriptional
induction of Blm-s and the apoptosis triggered by DSBs is
mediated through the ATM/p53 and JNK/AP1 pathways: two
well-documented routes to apoptosis that follow DNA damage
induced by various forms of neuronal injury. Upon DNA damage,
ATM is activated via phosphorylation at Ser1981, thereby acti-
vating its substrates such as p53 by phosphorylation at Ser15
or Ser20 and leading to transcriptional activation of various
p53 target genes (Zhou and Elledge, 2000). Alternatively, sus-
tained AP1 transcriptional activity produced by c-Jun phosphor-(E) Schematic diagram of BLM-s and its BH-domain mutants (Mut-BH2 and Mut
(F) Apoptotic rates caused by transfecting COS cells with BLM-s or its BH-doma
(G and H) TUNEL staining of E17.5 embryonic cortical sections transfected by IUE
arrows: TUNEL(+) GFP(+) cells. The scale bars represent 50 mm (white) and 500 mm
(I) Coimmunoprecipitation assays of COS cells cotransfected with Blm-s and the
(J) Anti-BLM-s antibody immunoprecipitates endogenous BCL-2 andMCL-1 from
nonspecific immunoglobulin light chain.
(K) GST pull-down of GST-fused BLM-s with His-BCL-2 (arrowhead) or His-MCL
(L) TUNEL staining of E17.5 embryonic cortical sections transfected with mCherry
TUNEL(+) mCherry(+) cells; Empty arrowheads: TUNEL() mCherry(+) GFP(+) ce
mCherry-BLM-s+siBax-GFP.
172 Cell Reports 9, 166–179, October 9, 2014 ª2014 The Authorsylation at Ser63 and Ser73 mediated by JNK could also lead to
neuronal apoptosis (Ham et al., 2000). We took a candidate
approach to evaluate the overall in vivo changes of the key
BCL-2 family proteins and members in the ATM/p53- and JNK/
AP1-signaling pathways in E15.5 embryonic brains within few
hours of recovery after g-IR. The immunoblots showed that acti-
vated caspase-3 was readily detected at 4 hr after g-IR, as evi-
denced by PARP cleavage (Figure 5A). Besides, the expression
levels of the BCL-2 family members including BCL-2, BLM-l,
BLM-s, and BAX decreased or increased gradually according
to their respective prosurvival and proapoptotic roles (Figures
5A and S6B). For both signaling pathways, ATM was apparently
activated at 4 hr after g-IR as shown by more phosphorylated
ATM at Ser1981 and by phosphorylation of ATM substrate
gH2A.X. Increased activity of both p53 and JNK was also de-
tected at 4 hr after g-IR as shown by phosphorylated p53 at
Ser15 and by phosphorylation of JNK and its substrate c-Jun
(Figure 5B). Consistent with these observations, in the g-IR-
treated embryonic cortices, double-labeling showed significant
increase in numbers of Blm-s-positive cortical neurons cos-
tained with phosphorylated p53 or phosphorylated c-Jun (Fig-
ures 5C and 5D).
Using dissociated embryonic cortical neurons, we also found
the expression level of Blm-s transcript was significantly in-
creased at 8 hr post-etoposide treatment (Figure 5E) and the
apoptosis was apparently induced 24 hr after the treatment.
We reasoned that, if the activation of the ATM/p53- and JNK/
AP1-signaling pathways was required for the etoposide-induced
induction of Blm-s transcription and concurrent apoptosis, phar-
macologically inhibiting these pathways with specific inhibitors
should prevent Blm-s from transcriptional activation and should
save cells from apoptotic death. Therefore, we inhibited ATM ac-
tivity in etoposide-treated cortical neurons by adding KU55933
or caffeine, inhibited p53 transactivation by pifithrin-a or pifi-
thrin-m, and blocked JNK activity by SP600125 or L-JNKi. As ex-
pected, each inhibitor caused a reduction in apoptosis with a
concomitant decrease in Blm-s mRNA expression (Figures 5F–
5H). Our findings indicate that, in postmitotic immature neurons,
Blm-s mRNA induction by DNA-damaging agents is mediated
through both ATM/p53- and JNK/AP1-signaling pathways.
Blm-s Is a Direct Target Gene of p53 and AP1
How is Blm-s mRNA upregulated by DSB signaling through the
ATM/p53 and JNK/AP1 pathways in the developing cortex?
We dissected the Blm-s promoter activity by luciferase reporter
assay up to 2 kb upstream of the designated transcription start-BH3).
in mutants. n = 5. WT, wild-type.
P at E14.5 either withBlm-s-Mut-BH3-GFP or with wild-typeBlm-s-GFP. White
(yellow). No. ofmice examined: five for BLM-s-GFP; eight for BLM-s-Mut-BH3.
indicated plasmids. BCL-2 and MCL-1, but not BAX, interacted with BLM-s.
the E15.5mouse embryonic brain extracts with or without g-irradiation (g-IR). *,
-1 (empty arrowhead).
-Blm-s plus siBax-GFP or with mCherry-Blm-s alone by IUEP at E14.5. Arrows:
lls. The scale bars represent 50 mm. No. of mice: 3 for mCherry-BLM-s; 11 for
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Figure 4. Blm-s Is Enriched in Postmitotic Immature Cortical Neurons, and Its Upregulation by Irradiation Coincides with Increased
Apoptosis
(A) Blm-s RNA in situ hybridization on E15.5, E16.5, and E17.5 cortical sections. MZ, marginal zone; see Figure 1B legend for CP, IZ, SVZ, and VZ.
(B) Expression of BLM-s proteins in the mouse brain during development and in adult by immunoblotting of brain lysates. For quantification (this and other
immunoblot figures), a-tubulin was used as a loading control and the ratio 1.0 is the condition set for comparison.
(legend continued on next page)
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site (TSS) and found that the genomic region ranging from nucle-
otide 140 to +84 (relative to the TSS of Blm-s) exhibited the
strongest promoter activity driven by nuclear lysate derived
from neuronal NG108 compared with that from nonneuronal
COS cells (Figure 6A). Bioinformatic analysis of this promoter re-
gion revealed multiple consensus binding sites for different tran-
scription factors (Figure 6A, upper right box). Among these sites
are an AP1-like element (TGTCTCATGC) from nucleotide 112
to 103 and a consensus p53-binding site from nucleotide +51
to +84, which suggests that Blm-s is a direct target gene of p53
and AP1.
This hypothesis was confirmed with five findings. First, chro-
matin immunoprecipitation (ChIP) showed that endogenous
phosphorylated p53 and c-Jun bound the defined Blm-s pro-
moter in embryonic cortex (Figure 6B), regardless of whether
there was g-IR to increase DSBs. In fact, g-IR treatment even
enhanced binding to the Blm-s promoter of the phosphorylated
p53 and the activated AP1 containing the phosphorylated c-Jun
in the embryonic cortex (Figure 6B). Second, electrophoresis
mobility shift assay indicated that the migration of a radio-
labeled DNA probe comprising either the putative AP1-binding
sequence or the p53-binding sequence in the Blm-s promoter
was retarded in a concentration-dependent manner by protein
extract from nuclei of E15.5 cortical neurons (Figures 6C, empty
arrowhead). Such mobility shift effects were specifically relieved
by cold-labeled probes and were supershifted by adding an
antibody against phosphorylated AP1 or p53 (Figures 6C, arrow-
head). Third, the increased luciferase reporter activity driven by
the nucleotide 140+83 region of the Blm-s promoter was
attenuated when either the putative p53-consensus binding
site or the AP1-like binding site was mutated, and this reporter
activity was greatly attenuated in p53-null mouse neuronal NE-
4C cells (Figure 6D, black bars). Fourth, activated p53 or AP1
was essential for DSB-induced Blm-s transcriptional activity
because inhibiting either ATM/p53- or JNK/AP1-signaling activ-
ity reduced the Blm-s promoter activity under etoposide treat-
ment (Figure 6E). The Blm-s promoter containing either a
mutated p53- or a mutated AP1-binding sequence exhibited
no increase in promoter activity caused by etoposide treatment
(Figure 6D, gray bars). Noticeably, inhibition of either ATM/p53-
or JNK/AP1-signaling activity also suppressed endogenous
Blm-s promoter activity (Figure S6C), suggesting that these
two signaling pathways play a crucial role to regulate endoge-
nous Blm-s expression. Fifth, the E15.5 p53/-null embryonic
forebrain exhibited much less Blm-s transcript than the p53+/+
wild-type or the p53+/ heterozygote forebrain (Figures 6F–6H).
Moreover, g-IR that induces the expression of Blm-s in the
wild-type embryonic forebrain failed to do so in the p53/ em-
bryonic forebrain (Figures 6F and 6H) with the concurrent strong(C) E15.5 cortical sections probed with Blm-s RNA and costained with postmi
precursor marker Ki67.
(D) E15.5 cortical sections probed with Blm-sRNA and costained with g-H2A.X. B
from four mice.
(E) Images of E15.5mouse cortical sections 4 hr post-5 Gy in utero g-IR detected b
(F and G) Images of sections of g-irradiated E18 cortex transfected with siBlm-s-G
Arrows: transfected (GFP+) cells with positive TUNEL staining (TUNEL+). Empty a
siScramble-GFP; nine for siBlm-s-GFP. The scale bars represent 50 mm for (A), (
174 Cell Reports 9, 166–179, October 9, 2014 ª2014 The Authorsresistance of p53/ brain to IR-induced apoptosis (Figure 6G).
All together, our data indicate that Blm-s is a direct target gene
of p53 and AP1 in response to DSBs in the developing embryonic
brain.
DISCUSSION
We report here the identification and characterization of a BCL-2
family member, BLM-s, which is specifically expressed in post-
mitotic immature neurons during cortical neurogenesis. In vivo
transfection of Blm-s cDNA in embryonic cortices and in vivo
knockdown of upregulated Blm-s after irradiation suggest
that BLM-s is likely to play a role in developmental neuronal
apoptosis. BLM-s contains both BH2 and BH3 domains. How-
ever, BLM-s directly binds to the prosurvival BCL-2 and MCL-
1 and promotes apoptosis through BAX-mediated mitochondrial
pathway, indicating it functions as a BH3-only apoptosis sensi-
tizer/derepressor. Importantly, we show that Blm-s can be upre-
gulated by p53 and AP1 in response to DNA damage.
Why the normal developing brain undergoes significant
apoptosis remains a mystery. Whereas the neurotrophic hypoth-
esis explains well for the culprit of the peripheral sensory and
motor neurons, it alone cannot account for the massive neuronal
apoptosis in the developing brain (Underwood, 2013). Instead,
recent evidence has indicated that the immature cortical neurons
are more susceptible to DNA damage and that increased
neuronal apoptosis is observed in mouse embryos with mutated
genes involved in the NHEJ DNA repair pathway, supporting an
alternative view that accumulation of irreparable DNA damage in
the immature neurons triggers apoptosis of the developing brain
(Frappart and McKinnon, 2008; Li et al., 2008; Gatz et al., 2011).
Indeed, we found that around 40% of embryonic cortical neu-
rons at E15.5 were positively labeled by the DSB marker
gH2A.X, suggesting a direct link of DNA damage to neuronal
apoptosis during cortical development. We also show that up
to 30% of gH2A.X-expressing postmitotic immature neurons at
E15.5 express Blm-s, implying a significant number of postmi-
totic neurons in the developing embryonic cortex accumulate
irreparable DNA damage and upregulate Blm-s to commit
neuronal apoptosis. Such DNA damage hypothesis is further
supported by the fact that most of the BCL-2 family members
expressed in the developing cortex including BAX, PUMA,
NOXA (Miyashita and Reed, 1995; Nakano and Vousden, 2001;
Oda et al., 2000), and BLM-s (this report) are the direct target
genes of p53, a pivotal transcription factor responsible for
neuronal apoptosis activated by DSBs (Enokido et al., 1996;
Frank et al., 2000; Miller et al., 2000; Culmsee and Mattson,
2005). Deletion of p53 gene in the embryonic cortex results in
a dramatic decrease in the expression level of both endogenoustotic neuronal markers Tuj1 and doublecortin (DCX) or proliferative neuronal
ar graph quantifies colocalization rate before and after 5 Gy g-IR. Each data are
yBlm-sRNA in situ hybridization or/and TUNEL stain. Ctx, cortex; Str, striatum.
FP by IUEP at E14.5 and costained with TUNEL. siScramble-GFP is a control.
rrowheads: transfected (GFP+) cells without TUNEL signal. No. of mice: six for
C), (D), and (F) and 100 mm for (E).
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Figure 5. Upregulation of Blm-s by DSB-Inducing Agents Is Mediated through ATM/p53- and JNK/AP1-Signaling Pathway
(A and B) Immunoblotting of the E15.5 forebrains 0–8 hr post-g-IR. See Figure 4B legend for quantification.
(C andD)Blm-sRNA insituandcoimmunostainingof eitherphospho-p53 (p-p53(ser15); C)orphospho-c-Jun (p-c-Jun(ser63); D) onsectionsofE15.5brains4hrpost-
g-IR.Highermagnification for theboxedarea is shown in the central panel. Arrows: colocalization. The scale bars represent 50mm.No. ofmice: three ormore for each.
(E) Semiquantitative RT-PCR analysis of Blm-s transcripts in DIV6 cortical neurons collected at the indicated hour after etoposide treatment. For quantification
(this and other RT-PCR figures), Gapdh was used for internal control and the ratio 1.0 is the condition set for comparison.
(F) Blm-s RNA in situ costained with TUNEL in DIV6 cortical neurons treated with etoposide plus the indicated inhibitor for 12 hr. PFT-a, PFT-m: p53 inhibitors;
KU55933, caffeine: ATM inhibitors; SP600125, L-JNKi: JNK inhibitors. The scale bar represents 10 mm.
(G) Semiquantitative RT-PCR analysis of Blm-s transcripts in DIV6 cortical neurons treated with etoposide plus the indicated inhibitor for 12 hr.
(H) Apoptotic rate induced by the indicated treatment in DIV6 cortical neurons. n = 6 assays.
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and IR-induced Blm-s. Together, these data strongly indicate
that the ATM/p53-signaling pathway mediates the expression
of Blm-s in vivo, which is highly related to the naturally occurring
DSBs and neuronal apoptosis during normal brain development.
Our results also show that only a fraction of immature neurons
expressingBlm-s undergo apoptosis. This could be explained by
the rheostat model, in which the decision of cell death depends
on the overall effect of existing BCL-2 family members. Alterna-
tively, a potential dynamic regulation of BLM-s protein level in
each neuron might affect the cell fate decision. It has recently
been well recognized that the dynamic regulations of p53 and
ATM phosphorylation in single cells in response to DNA damage
are important for the cell death decision (Purvis et al., 2012; Pur-
vis and Lahav, 2013). Being a direct downstream effector of p53,
BLM-s’s protein level in cell might be dynamically regulated such
that only a subset of immature neurons is committed to the death
fate. Apparently, more work such as measurement of BLM-s
in single cells or analysis of Blm-s mutant mice is required to
conclusively demonstrate the exact role of Blm-s in develop-
mental neuronal apoptosis.
It is generally believed that, during cortical neurogenesis,
regulation of apoptosis in the proliferative zone is controlled by
a mechanism distinct from that used in the postmitotic zone.
These mechanisms exert concordant selective pressure to con-
trol the total cell number and types of the postnatal cortex (Nijha-
wan et al., 2000). The choice of mechanism is in part regulated
by cell- or tissue-specific expression of the core apoptosis mo-
lecular machinery including caspases and the BCL-2 family
members. For example, apoptosis in migrating neurons of the
postmitotic zone needs caspase-3, whereas apoptosis in
neuronal precursor cells of the proliferative zone requires cas-
pase-9, but not caspase-3 (D’Sa-Eipper et al., 2001). Subsets
of BCL-2 family members are also differentially expressed
throughout embryonic brain development so that the predomi-
nant prosurvival protein expressed in the proliferative neuronal
precursors is BCL-2 at E10.5, but at later embryonic stages,
this role is replaced by MCL-1. At E16.5, BCL-2 localizes pre-
dominantly in the postmitotic cortical plate where MCL-1 andFigure 6. Blm-s Is a Direct Target Gene of p53 and AP1
(A) Relative luciferase activity to define the Blm-s promoter region. Serial deletion
neuronal NG108 and nonneuronal COS cells. Fold changes are normalized to
efficiency. The numbers indicate the nucleotide position relative to the ATG in
endogenous Blm-s is present in NG108 cells, but not in COS cells. Right up
Blm-s(140+87) promoter region.
(B) Chromatin immunoprecipitation (ChIP) performed in untreated or g-IR-treate
bodies. Bar graphs show the quantification of ChIP results (nR 3). ChIP efficien
signal. IgG, immunoglobulin G.
(C) Electrophoretic mobility shift assays with the nuclear protein extract derived
addition; empty arrowheads, without antibody treatment.
(D) Diagram ofBlm-s(140+87) promoter mutant variants including a p53-bindin
mutant lacking the AP1-binding site (Blm-s(31+87)). Bar graph shows the res
poside treatment. Also compared are the promoter activities ofBlm-s(140+87)
acid treatment. Black bar, no treatment; gray bar, etoposide treatment. n = 6.
(E) Luciferase activity assays in NG108 cells treated with etoposide plus inhibito
treatment; gray bars, etoposide treatment. n = 6 assays.
(F) Images of Blm-s RNA in situ hybridization of the p53-null (p53/), heterozygot
The scale bars represent 100 mm.
(G) TUNEL staining of these p53 mutant brains with g-IR. The scale bar represen
(H) Semiquantitative RT-PCR analysis of Blm-s, Bax, and P53 transcripts in thes
floxed (p53 knockout) allele (upper band) and the 335 bp wild-type allele (lower bBCL-xL are also expressed (Krajewska et al., 2002; Lindsten
et al., 2005). In proliferating neuronal precursors, the BH3-only
proapoptotic PUMA, NOXA, and tBID are required for develop-
mental apoptosis (Ren et al., 2010). However, for apoptosis in
postmitotic migrating neurons in the IZ/CP region, the critical
BH3-only proteins are not known in spite of several mouse ge-
netic-disruption studies (Leonard et al., 2001; Ranger et al.,
2001; Akhtar et al., 2008; Ghosh et al., 2011). The concurrent
expression of BAX, BCL-2,MCL-1, caspase 3with BLM-s seems
to be highly restricted in postmitotic neurons at E15–E17, and
their mutual biochemical interactions as we have demonstrated
suggest that BLM-s could be the potential BH3-only sensor/initi-
ator for postmitotic neuronal apoptosis.
An evolutionary tree analysis of the BCL-2 family reveals that
the multidomain BCL-2 members emerged when multicellu-
larity of metazoans was developing, whereas BH3-only pro-
teins, which are evolutionarily more diverse, might have evolved
later in order to regulate specific death and survival pathways in
response to distinct signals (Aouacheria et al., 2005, 2013). In
accordance, interspecies comparison of DNA sequences re-
veals that Blm-s is highly conserved among mammals and is
only distantly related to its paralogs in lower vertebrates.
Thus, Blm-s may have evolved as a functional necessity for
the expansion and complexity of the nervous system in
mammals.EXPERIMENTAL PROCEDURES
Information about plasmid constructs and antibodies and procedures for RNA
differential display, primer extension, northern and western blotting, yeast
two-hybrid, cell culture, ChIP, electrophoretic mobility shift assay, luciferase
reporter assay, coimmunoprecipitation, GST pull-down, subcellular fraction-
ation, RNA in situ hybridization, cryo-immunogold electron microscopy,
immunohistochemistry, and immunofluorescence microscopy are listed in
Supplemental Information.
Dissociated Cortical Neuronal Culture
For dissociated neuronal culture, E15.5 forebrain cortices from C57BL/6 mice
were dissected and digested with trypsin (0.25%) and DNase I (50 mg/ml) ats of Blm-s promoter-luciferase constructs were generated and transfected into
the activity of pGL3-promoterless construct and corrected with transfection
itiator methionine. Lower right box shows the RT-PCR result indicating that
per box diagrams the predicted transcriptional-factor-binding sites on the
d E15.5 embryonic brains with anti-phospho-p53 or anti-phospho-c-Jun anti-
cy is defined as the percentage of the precipitated signal to the genomic input
from E15.5 embryonic forebrain with/without g-IR. Arrowheads, with antibody
g site mutant (mut p53), an AP1-binding site mutant (mut AP1), and a truncated
ults of promoter luciferase activity assays in NG108 cells with or without eto-
in p53-deficient NE-4C cells without (p53/) or with (p53/, neuronal) retinoic
rs of either the ATM/p53- or the JNK/AP1-signaling pathways. Black bar, no
e (p53+/), and wild-type (p53+/+) mouse embryonic brains with or without g-IR.
ts 100 mm.
e p53 mutant brains. Allele-specific PCR was used to distinguish the 548 bp
and).
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37C for 7 min, followed by trituration. We plated 33 105 cells onto 35 mm cell
culture dishes (precoated with 33 mg/ml poly-D-L-lysine and 4 mg/ml laminin) in
Neurobasal medium supplemented with B27, GlutaMax (Life Technologies),
BDNF (or NGF for dorsal root ganglion [DRG] culture), and 1% penicillin/strep-
tomycin and incubated at 37C in a 5%CO2 incubator. The GFAP-positive glia
contamination from the dissociated cortical neurons cultured in vitro for 6 days
(DIV6) is less than 1%. Transient transfection was performed by Lipofectamine
2000 (Invitrogen) or by electroporation (Bio-Rad).
In Utero Intraventricular Electroporation and Irradiation Exposure
For IUEP, the pregnant mouse was anesthetized with Avertin (Sigma) and the
abdominal wall was incised along its midline. Five micrograms endotoxin-free
plasmids containing 0.01% Fast Green were injected into the lateral ventricle
of each embryo by using a glass micropipette. For in vivo RNAi, H1 promoter-
driven small interfering RNA vectors plus PGK promoter-driven GFP marker
were used. For in vivo overexpression, CAG promoter-driven constructs
were used. During electroporation, four 50 ms pulses of 35 V at 950 ms inter-
vals were delivered by a CUY21 electroporator (Tokiwa Science). After the
IUEP, embryos were returned into the female mouse and the incision was su-
tured. The recovering pregnant females were kept for 2 to 3 days before they
were sacrificed for examination. Exposure of mice or cells to g-IR was per-
formed using a 137cesium source (Department of Radiology, National Taiwan
University Hospital). Exposure of cells to UV C radiation was performed using
Ultraviolet Crosslinkers CL-1000 (UVP). All animal experiments were per-
formed according to institutional guidelines and through an Institutional-Ani-
mal-Care-and-Use-Committee-approved protocol (no. 20110017).
Statistical Analysis
To quantify the neurons that showed colocalization ofBlm-s expressionwith p-
c-Jun, p-p53, or TUNEL in E15.5 cerebral cortex, images were captured at 400
3 magnification over 1215 coronal sections that exhibited the fluorescent
signals (i.e., the regions that expressed the IUEP-injected plasmid). At least
three mice for each experimental condition (n = 310) were used. Quantifica-
tion data are presented as mean ± SD. We used a two-tailed unpaired
Student’s t test for statistical analysis between two groups with the following
designations: ***p < 0.001; **p < 0.01; *p < 0.05.
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